Skip to main content
Erschienen in: International Urogynecology Journal 1/2008

01.01.2008 | Original Article

Analysis of risk factors associated with vaginal erosion after synthetic sling procedures for stress urinary incontinence

verfasst von: Huey-Yi Chen, Ming Ho, Yao-Ching Hung, Li-Chia Huang

Erschienen in: International Urogynecology Journal | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

The goal of this study was to analyze the risk factors associated with vaginal erosion after synthetic sling procedure for stress urinary incontinence. Follow-up evaluations were at 1 week, 1 to 3 months, 6 months, and annually after the operation. The evaluations included detailed history taking, vaginal examinations, and perineal ultrasonographic urethrocystography. The vaginal erosion rate (6/239) after the synthetic sling procedure was 2.5%. We assessed the relationship between clinical features and vaginal erosion. Of these, only diabetes mellitus (DM) was a significant risk factor for vaginal erosion. Women with DM were 8.3 times more at risk than women without DM for developing vaginal erosion after synthetic sling procedure (p < 0.05). The vaginal erosion-free rate during the 24-month follow-up decreased significantly in women with DM. The rate of vaginal erosion associated with type III multifilamentous polypropylene sling (intravaginal slingplasty) is 10.7% more than that with type I monofilament polypropylene sling (such as tension-free vaginal tape and inside out transobturator vaginal tape) (p = 0.054). Women with DM should be informed that vaginal erosion is a possible complication after synthetic sling procedure.
Literatur
1.
Zurück zum Zitat Ulmsten U, Henriksson L, Johnson P, Varhos G (1996) An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 7:81–86PubMedCrossRef Ulmsten U, Henriksson L, Johnson P, Varhos G (1996) An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 7:81–86PubMedCrossRef
2.
Zurück zum Zitat Baessler K, Maher CF (2006) Mesh augmentation during pelvic-floor reconstructive surgery: risks and benefits. Curr Opin Obstet Gynecol 18:560–566PubMedCrossRef Baessler K, Maher CF (2006) Mesh augmentation during pelvic-floor reconstructive surgery: risks and benefits. Curr Opin Obstet Gynecol 18:560–566PubMedCrossRef
3.
Zurück zum Zitat Flock F, Reich A, Muche R, Kreienberg R, Reister F (2004) Hemorrhagic complications associated with tension-free vaginal tape procedure. Obstet Gynecol 104:989–994PubMed Flock F, Reich A, Muche R, Kreienberg R, Reister F (2004) Hemorrhagic complications associated with tension-free vaginal tape procedure. Obstet Gynecol 104:989–994PubMed
4.
Zurück zum Zitat de Leval J (2003) Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol 44:724–730PubMedCrossRef de Leval J (2003) Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol 44:724–730PubMedCrossRef
5.
Zurück zum Zitat Karram MM, Segal JL, Vassallo BJ, Kleeman SD (2003) Complications and untoward effects of the tension-free vaginal tape procedure. Obstet Gynecol 101:929–932PubMedCrossRef Karram MM, Segal JL, Vassallo BJ, Kleeman SD (2003) Complications and untoward effects of the tension-free vaginal tape procedure. Obstet Gynecol 101:929–932PubMedCrossRef
6.
Zurück zum Zitat Deval B, Haab F (2006) Management of the complications of the synthetic slings. Curr Opin Urol 16:240–243PubMedCrossRef Deval B, Haab F (2006) Management of the complications of the synthetic slings. Curr Opin Urol 16:240–243PubMedCrossRef
7.
Zurück zum Zitat Petros P, Ulmsten U (1993) The development of the intravaginal slingplasty procedure: IVS II–VI. Scand J Urol Nephrol Suppl 153:61–84 Petros P, Ulmsten U (1993) The development of the intravaginal slingplasty procedure: IVS II–VI. Scand J Urol Nephrol Suppl 153:61–84
8.
Zurück zum Zitat Meschia M, Pifarotti P, Bernasconi F, Guercio E, Maffiolini M, Magatti F et al (2001) Tension-free vaginal tape analysis of outcomes and complications in 404 stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct 12 (Suppl):S24–S27PubMedCrossRef Meschia M, Pifarotti P, Bernasconi F, Guercio E, Maffiolini M, Magatti F et al (2001) Tension-free vaginal tape analysis of outcomes and complications in 404 stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct 12 (Suppl):S24–S27PubMedCrossRef
9.
Zurück zum Zitat Kuuva N, Nilsson CG (2002) A nationwide analysis of complications associated with the tension-free vaginal tape (TVT) procedure. Acta Obstet Gynecol Scand 81:72–77PubMedCrossRef Kuuva N, Nilsson CG (2002) A nationwide analysis of complications associated with the tension-free vaginal tape (TVT) procedure. Acta Obstet Gynecol Scand 81:72–77PubMedCrossRef
10.
Zurück zum Zitat Levin I, Groutz A, Gold R, Pauzner D, Lessing JB, Gordon D (2004) Surgical complications and medium-term outcome results of tension-free vaginal tape: a prospective study of 313 consecutive patients. Neurourol Urodyn 23:7–9PubMedCrossRef Levin I, Groutz A, Gold R, Pauzner D, Lessing JB, Gordon D (2004) Surgical complications and medium-term outcome results of tension-free vaginal tape: a prospective study of 313 consecutive patients. Neurourol Urodyn 23:7–9PubMedCrossRef
11.
Zurück zum Zitat Bafghi A, Benizri EI, Trastour C, Benizri EJ, Michiels JF, Bongain A (2005) Multifilament polypropylene mesh for urinary incontinence: 10 cases of infections requiring removal of the sling. BJOG 112:376–378PubMedCrossRef Bafghi A, Benizri EI, Trastour C, Benizri EJ, Michiels JF, Bongain A (2005) Multifilament polypropylene mesh for urinary incontinence: 10 cases of infections requiring removal of the sling. BJOG 112:376–378PubMedCrossRef
12.
Zurück zum Zitat Baessler K, Hewson AD, Tunn R, Schuessler B, Maher CF (2005) Severe mesh complications following intravaginal slingplasty. Obstet Gynecol 106:713–716PubMed Baessler K, Hewson AD, Tunn R, Schuessler B, Maher CF (2005) Severe mesh complications following intravaginal slingplasty. Obstet Gynecol 106:713–716PubMed
13.
Zurück zum Zitat Glavind K, Sander P (2004) Erosion, defective healing and extrusion after tension-free urethropexy for the treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 15:179–182PubMedCrossRef Glavind K, Sander P (2004) Erosion, defective healing and extrusion after tension-free urethropexy for the treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 15:179–182PubMedCrossRef
14.
Zurück zum Zitat Cervigni M, Natale F (2001) The use of synthetics in the treatment of pelvic organ prolapse. Curr Opin Urol 11:429–435PubMedCrossRef Cervigni M, Natale F (2001) The use of synthetics in the treatment of pelvic organ prolapse. Curr Opin Urol 11:429–435PubMedCrossRef
15.
Zurück zum Zitat Takoudes TC, Weitzen S, Slocum J, Malee M (2004) Risk of cesarean wound complications in diabetic gestations. Am J Obstet Gynecol 191:958–963PubMedCrossRef Takoudes TC, Weitzen S, Slocum J, Malee M (2004) Risk of cesarean wound complications in diabetic gestations. Am J Obstet Gynecol 191:958–963PubMedCrossRef
16.
Zurück zum Zitat Onodera H, Ikeuchi D, Nagayama S, Imamura M (2004) Weakness of anastomotic site in diabetic rats is caused by changes in the integrity of newly formed collagen. Dig Surg 21:146–151PubMedCrossRef Onodera H, Ikeuchi D, Nagayama S, Imamura M (2004) Weakness of anastomotic site in diabetic rats is caused by changes in the integrity of newly formed collagen. Dig Surg 21:146–151PubMedCrossRef
17.
Zurück zum Zitat Wang AC, Lee LY, Lin CT, Chen JR (2004) A histologic and immunohistochemical analysis of defective vaginal healing after continence taping procedure: a prospective case-controlled pilot study. Am J Obstet Gynecol 191:1868–1874PubMedCrossRef Wang AC, Lee LY, Lin CT, Chen JR (2004) A histologic and immunohistochemical analysis of defective vaginal healing after continence taping procedure: a prospective case-controlled pilot study. Am J Obstet Gynecol 191:1868–1874PubMedCrossRef
18.
Zurück zum Zitat Bent AE, Ostergard DR, Zwick-Zaffuto M (1993) Tissue reaction to expanded polytetrafluoroethylene suburethral sling for urinary incontinence: clinical and histologic study. Am J Obstet Gynecol 169:1198–1204PubMed Bent AE, Ostergard DR, Zwick-Zaffuto M (1993) Tissue reaction to expanded polytetrafluoroethylene suburethral sling for urinary incontinence: clinical and histologic study. Am J Obstet Gynecol 169:1198–1204PubMed
19.
Zurück zum Zitat Achtari C, Hiscock R, O’Reilly BA, Schierlitz L, Dwyer PL (2005) Risk factors for mesh erosion after transvaginal surgery using polypropylene (Atrium) or composite polypropylene/polyglactin 910 (Vypro II) mesh. Int Urogynecol J Pelvic Floor Dysfunct 16:389–394PubMedCrossRef Achtari C, Hiscock R, O’Reilly BA, Schierlitz L, Dwyer PL (2005) Risk factors for mesh erosion after transvaginal surgery using polypropylene (Atrium) or composite polypropylene/polyglactin 910 (Vypro II) mesh. Int Urogynecol J Pelvic Floor Dysfunct 16:389–394PubMedCrossRef
Metadaten
Titel
Analysis of risk factors associated with vaginal erosion after synthetic sling procedures for stress urinary incontinence
verfasst von
Huey-Yi Chen
Ming Ho
Yao-Ching Hung
Li-Chia Huang
Publikationsdatum
01.01.2008
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 1/2008
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-007-0400-2

Weitere Artikel der Ausgabe 1/2008

International Urogynecology Journal 1/2008 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.